A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already resulted in 57% lower than expected hospitalizations in WA, saving the health system $6.2–6.9 million, according to Australian experts. The experts say the availability of vaccines is “an era-defining advancement in RSV prevention.”
This article was originally published on MedicalXpress.com